{"id":"https://openalex.org/W4393085484","doi":"https://doi.org/10.1158/1538-7445.am2024-4503","title":"Abstract 4503: Preclinical characterization of PRT7732: A highly potent, selective, and orally bioavailable targeted protein degrader of SMARCA2","display_name":"Abstract 4503: Preclinical characterization of PRT7732: A highly potent, selective, and orally bioavailable targeted protein degrader of SMARCA2","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393085484","doi":"https://doi.org/10.1158/1538-7445.am2024-4503"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-4503","doi":"https://doi.org/10.1158/1538-7445.am2024-4503","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-4503","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004348569","display_name":"Artem Shvartsbart","orcid":"https://orcid.org/0000-0002-1438-3095","observed_orcids":["https://orcid.org/0000-0002-1438-3095"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Artem Shvartsbart","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008877870","display_name":"Koichi Ito","orcid":"https://orcid.org/0000-0001-8635-6080","observed_orcids":["https://orcid.org/0000-0001-8635-6080"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Koichi Ito","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004443645","display_name":"Joseph D. Rager","orcid":"https://orcid.org/0009-0004-6008-9630","observed_orcids":["https://orcid.org/0009-0004-6008-9630"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Rager","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091867223","display_name":"Michael Hulse","orcid":"https://orcid.org/0000-0002-6691-365X","observed_orcids":["https://orcid.org/0000-0002-6691-365X","https://orcid.org/0009-0000-7928-1842"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Hulse","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034853468","display_name":"Anjana Agarwal","orcid":"https://orcid.org/0009-0008-7625-1240","observed_orcids":["https://orcid.org/0009-0008-7625-1240"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anjana Agarwal","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049083963","display_name":"Komali Vykuntam","orcid":"https://orcid.org/0009-0004-4538-4535","observed_orcids":["https://orcid.org/0009-0004-4538-4535"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Komali Vykuntam","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030876681","display_name":"Jessica Burtell","orcid":"https://orcid.org/0000-0002-7763-6379","observed_orcids":["https://orcid.org/0000-0002-7763-6379"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica Burtell","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Min Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Min Wang","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110657284","display_name":"Justin J. Kurian","orcid":"https://orcid.org/0009-0006-5412-3681","observed_orcids":["https://orcid.org/0009-0006-5412-3681"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin Kurian","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034085965","display_name":"Miles Cowart","orcid":"https://orcid.org/0009-0006-1839-9242","observed_orcids":["https://orcid.org/0009-0006-1839-9242"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Miles Cowart","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084127002","display_name":"Joy M. Cote","orcid":"https://orcid.org/0000-0002-2570-267X","observed_orcids":["https://orcid.org/0000-0002-2570-267X"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joy Cote","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113149838","display_name":"Nick Stahl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nick Stahl","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017032244","display_name":"Monisha Sivakumar","orcid":"https://orcid.org/0009-0002-8937-4289","observed_orcids":["https://orcid.org/0009-0002-8937-4289"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Monisha Sivakumar","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5094221960","display_name":"Anthony Reichelderfer","orcid":"https://orcid.org/0009-0008-0073-3403","observed_orcids":["https://orcid.org/0009-0008-0073-3403"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony Reichelderfer","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052263916","display_name":"Jack Carter","orcid":"https://orcid.org/0000-0002-7784-7897","observed_orcids":["https://orcid.org/0000-0002-7784-7897"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jack Carter","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069730078","display_name":"Alexander Grego","orcid":"https://orcid.org/0009-0000-8724-7003","observed_orcids":["https://orcid.org/0009-0000-8724-7003"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Grego","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101927522","display_name":"Andrew Moore","orcid":"https://orcid.org/0009-0005-4080-5676","observed_orcids":["https://orcid.org/0009-0005-4080-5676"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Moore","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060435781","display_name":"Neha Bhagwat","orcid":"https://orcid.org/0009-0002-5766-0272","observed_orcids":["https://orcid.org/0009-0002-5766-0272"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neha Bhagwat","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047122505","display_name":"Ross Kuskovsky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ross Kuskovsky","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112255711","display_name":"Shanthi Ganesan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shanthi Ganesan","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048703920","display_name":"Stefan U. Ruepp","orcid":"https://orcid.org/0009-0008-7476-7614","observed_orcids":["https://orcid.org/0009-0008-7476-7614"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefan Ruepp","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113149839","display_name":"Tom Emm","orcid":"https://orcid.org/0009-0006-0288-9626","observed_orcids":["https://orcid.org/0009-0006-0288-9626"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tom Emm","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004765672","display_name":"Philip M. Pitis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip Pitis","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027819876","display_name":"Corey Hannah Basch","orcid":"https://orcid.org/0000-0003-4862-4229","observed_orcids":["https://orcid.org/0000-0003-4862-4229"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Corey Basch","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032803103","display_name":"Klare L. Bersch","orcid":"https://orcid.org/0009-0004-6382-1313","observed_orcids":["https://orcid.org/0009-0004-6382-1313"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Klare Bersch","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102605139","display_name":"Yongchun Pan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yongchun Pan","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100941475","display_name":"Song Mei","orcid":"https://orcid.org/0009-0002-9382-9266","observed_orcids":["https://orcid.org/0009-0002-9382-9266"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Song Mei","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Raul Leal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raul Leal","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067116063","display_name":"JOHN W. ROSE","orcid":"https://orcid.org/0000-0003-2382-5921","observed_orcids":["https://orcid.org/0000-0003-2382-5921","https://orcid.org/0000-0002-0894-5506"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Rose","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109694500","display_name":"Dani Roth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dani Roth","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090850096","display_name":"Chaoyi Xu","orcid":"https://orcid.org/0000-0002-9870-4297","observed_orcids":["https://orcid.org/0000-0002-9870-4297"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chaoyi Xu","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009519373","display_name":"Ganfeng Cao","orcid":"https://orcid.org/0000-0003-3468-2057","observed_orcids":["https://orcid.org/0000-0003-3468-2057"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ganfeng Cao","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046355139","display_name":"Kris Vaddi","orcid":"https://orcid.org/0009-0009-8581-6511","observed_orcids":["https://orcid.org/0009-0009-8581-6511"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kris Vaddi","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100444567","display_name":"Sang\u2010Hyun Lee","orcid":"https://orcid.org/0000-0002-9682-1473","observed_orcids":["https://orcid.org/0000-0002-9682-1473"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sang Hyun Lee","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004633647","display_name":"Sandy Geeganage","orcid":"https://orcid.org/0009-0002-4608-8012","observed_orcids":["https://orcid.org/0009-0002-4608-8012"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sandy Geeganage","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022438790","display_name":"Andrew P. Combs","orcid":"https://orcid.org/0000-0003-1418-5168","observed_orcids":["https://orcid.org/0000-0003-1418-5168"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Combs","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018193992","display_name":"Peggy Scherle","orcid":"https://orcid.org/0000-0003-0783-6815","observed_orcids":["https://orcid.org/0000-0003-0783-6815"]},"institutions":[{"id":"https://openalex.org/I4405265449","display_name":"Prelude Therapeutics Incorporated (United States)","ror":"https://ror.org/04v7ftc96","country_code":"US","type":"company","lineage":["https://openalex.org/I4405265449"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peggy Scherle","raw_affiliation_strings":["1Prelude Therapeutics, Wilmington, DE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Prelude Therapeutics, Wilmington, DE","institution_ids":["https://openalex.org/I4405265449"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405265449"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"4503","last_page":"4503"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/smarca2","display_name":"SMARCA2","score":0.9300000071525574},{"id":"https://openalex.org/keywords/brg1","display_name":"SMARCA4","score":0.7770000100135803},{"id":"https://openalex.org/keywords/targeted-protein-degradation","display_name":"targeted protein degradation","score":0.8119999766349792},{"id":"https://openalex.org/keywords/synthetic-lethality","display_name":"synthetic lethality","score":0.8180000185966492},{"id":"https://openalex.org/keywords/swi-snf-complex","display_name":"SWI/SNF complex","score":0.7549999952316284},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.6729999780654907},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.9120000004768372},{"id":"https://openalex.org/keywords/ubiquitin-proteasome-degradation","display_name":"ubiquitin-proteasome degradation","score":0.8970000147819519},{"id":"https://openalex.org/keywords/neddylation","display_name":"neddylation","score":0.6769999861717224},{"id":"https://openalex.org/keywords/bromodomain","display_name":"bromodomain","score":0.6119999885559082},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.5460000038146973},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.6110000014305115}],"concepts":[{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6681405901908875},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47896483540534973},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45251938700675964},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3929538428783417},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3378635346889496}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-4503","doi":"https://doi.org/10.1158/1538-7445.am2024-4503","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-4503","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4282925667","https://openalex.org/W4389240577","https://openalex.org/W4362536125","https://openalex.org/W4414465618","https://openalex.org/W4393071848","https://openalex.org/W3181307558","https://openalex.org/W4409625770","https://openalex.org/W4389239771","https://openalex.org/W4409630300","https://openalex.org/W4393085520"],"abstract_inverted_index":{"Abstract":[0],"SWI/SNF":[1,27],"(BAF)":[2],"complexes":[3],"play":[4],"an":[5,30],"important":[6],"role":[7],"in":[8,41,70,104,126,132,136,194,201,213,220,273,276,279,287,291],"controlling":[9],"gene":[10,62],"expression":[11,38],"by":[12,147],"remodeling":[13],"chromatin.":[14],"SMARCA2":[15,63,69,75,97,123,143,205,225,256,268,390],"(BRM)":[16],"and":[17,33,49,52,112,151,173,278,290,383],"SMARCA4":[18,36,82,125,191,211,215],"(BRG1)":[19],"are":[20,56,296],"the":[21,26,137,224,395],"core":[22],"catalytic":[23],"subunits":[24],"of":[25,94,164,198,204,240,377,389,394],"complexes,":[28],"containing":[29],"ATPase":[31],"domain":[32],"a":[34,92,148,214],"bromodomain.":[35],"protein":[37,206,212,257,387],"is":[39],"lost":[40],"some":[42],"cancers":[43,72,275],"due":[44],"to":[45,282],"loss-of-function":[46],"(LOF)":[47],"mutations":[48],"homozygous":[50],"deletions,":[51],"SMARCA4-deleted":[53],"cancer":[54,133,179,218,243],"cells":[55,193],"highly":[57,380],"dependent":[58,156],"on":[59],"its":[60],"paralog":[61],"for":[64,122,259,398],"their":[65],"survival.":[66],"Therefore,":[67],"targeting":[68],"SMARCA4-deficient":[71,178,241,274],"using":[73],"selective":[74,98],"degraders":[76,99,269],"induces":[77],"synthetic":[78,271],"lethality":[79,272],"while":[80],"sparing":[81],"wild":[83],"type":[84],"(WT)":[85],"normal":[86],"cells.":[87],"We":[88],"have":[89],"recently":[90],"identified":[91],"series":[93],"orally":[95,266,384],"bioavailable":[96,267,385],"that":[100],"demonstrate":[101],"robust":[102,255],"efficacy":[103],"pre-clinical":[105],"animal":[106],"models":[107,245,289],"with":[108,129,182,207,223,293],"favorable":[109],"pharmacokinetic":[110],"properties":[111],"safety":[113],"profiles.":[114],"Our":[115],"nomination":[116],"candidate":[117],"PRT7732":[118,159,175,199,231],"exhibits":[119],">1000x":[120],"selectivity":[121,209],"over":[124,210],"cell-based":[127],"assays,":[128],"DC50":[130],"values":[131,184],"cell":[134,180],"lines":[135],"low":[138],"nanomolar":[139],"range.":[140],"The":[141,250],"PRT7732-induced":[142],"degradation":[144,203,226],"was":[145],"rescued":[146],"proteasome":[149],"inhibitor":[150],"neddylation":[152],"inhibitor,":[153],"indicating":[154],"ubiquitin-proteasome":[155],"degradation.":[157],"Furthermore,":[158],"does":[160],"not":[161,190],"change":[162],"levels":[163],"known":[165],"CRBN":[166],"ligand":[167],"neo-substrates":[168],"such":[169],"as":[170],"IKZF2/3,":[171],"GSPT1":[172],"SALL4.":[174],"inhibits":[176],"only":[177],"proliferation":[181],"IC50":[183],"ranging":[185],"from":[186],"5.0-50":[187],"nM,":[188],"but":[189],"WT":[192,216],"vitro.":[195],"Oral":[196],"administration":[197,234],"resulted":[200],"near-total":[202],"complete":[208],"lung":[217,242],"model":[219],"mice,":[221],"consistent":[222],"kinetics-based":[227],"pharmacodynamic":[228],"prediction":[229],"model.":[230],"oral":[232],"daily":[233],"showed":[235],"significant":[236],"tumor":[237,252],"growth":[238],"inhibition":[239],"xenograft":[244],"at":[246],"well":[247],"tolerated":[248],"doses.":[249],"treated":[251],"tissues":[253],"show":[254],"reduction":[258],"24h":[260],"post":[261],"dosing.":[262],"In":[263],"summary,":[264],"our":[265],"induce":[270],"vitro":[277],"vivo.":[280],"Efforts":[281],"further":[283],"evaluate":[284],"these":[285],"compounds":[286],"additional":[288],"combination":[292],"other":[294],"agents":[295],"ongoing.":[297],"Citation":[298],"Format:":[299],"Artem":[300],"Shvartsbart,":[301],"Koichi":[302],"Ito,":[303],"Joseph":[304],"Rager,":[305],"Michael":[306],"Hulse,":[307],"Anjana":[308],"Agarwal,":[309],"Komali":[310],"Vykuntam,":[311],"Jessica":[312],"Burtell,":[313],"Min":[314],"Wang,":[315],"Justin":[316],"Kurian,":[317],"Miles":[318],"Cowart,":[319],"Joy":[320],"Cote,":[321],"Nick":[322],"Stahl,":[323],"Monisha":[324],"Sivakumar,":[325],"Anthony":[326],"Reichelderfer,":[327],"Jack":[328],"Carter,":[329],"Alexander":[330],"Grego,":[331],"Andrew":[332,371],"Moore,":[333],"Neha":[334],"Bhagwat,":[335],"Ross":[336],"Kuskovsky,":[337],"Shanthi":[338],"Ganesan,":[339],"Stefan":[340],"Ruepp,":[341],"Tom":[342],"Emm,":[343],"Philip":[344],"Pitis,":[345],"Corey":[346],"Basch,":[347],"Klare":[348],"Bersch,":[349],"Yongchun":[350],"Pan,":[351],"Song":[352],"Mei,":[353],"Raul":[354],"Leal,":[355],"John":[356],"Rose,":[357],"Dani":[358],"Roth,":[359],"Chaoyi":[360],"Xu,":[361],"Ganfeng":[362],"Cao,":[363],"Kris":[364],"Vaddi,":[365],"Sang":[366],"Hyun":[367],"Lee,":[368],"Sandy":[369],"Geeganage,":[370],"Combs,":[372],"Peggy":[373],"Scherle.":[374],"Preclinical":[375],"characterization":[376],"PRT7732:":[378],"A":[379],"potent,":[381],"selective,":[382],"targeted":[386],"degrader":[388],"[abstract].":[391],"In:":[392],"Proceedings":[393],"American":[396],"Association":[397],"Cancer":[399,417],"Research":[400],"Annual":[401],"Meeting":[402],"2024;":[403],"Part":[404],"1":[405],"(Regular":[406],"Abstracts);":[407],"2024":[408],"Apr":[409],"5-10;":[410],"San":[411],"Diego,":[412],"CA.":[413],"Philadelphia":[414],"(PA):":[415],"AACR;":[416],"Res":[418],"2024;84(6_Suppl):Abstract":[419],"nr":[420],"4503.":[421]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2024-03-23T00:00:00"}